Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience

Ann Allergy Asthma Immunol. 2015 Dec;115(6):536. doi: 10.1016/j.anai.2015.09.012.

Authors

Luis Felipe Ensina¹, Alex Eustáquio de Lacerda², Ligia Maria de Oliveira Machado², Inês Camelo-Nunes³, Dirceu Solé²

Affiliations

¹ Federal University of São Paulo, São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil. Electronic address: 100alergia@gmail.com.
² Federal University of São Paulo, São Paulo, Brazil.
³ Federal University of São Paulo, São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil.

PMID: 26653279
DOI: 10.1016/j.anai.2015.09.012

No abstract available

Publication types

Letter

MeSH terms

Adult
Anti-Allergic Agents / therapeutic use*
Chronic Disease
Female
Humans
Male
Omalizumab / therapeutic use*
Treatment Outcome
Urticaria / drug therapy*

Substances

Anti-Allergic Agents
Omalizumab